百花医药
(600721)
| 流通市值：50.41亿 | | | 总市值：50.41亿 |
| 流通股本：3.85亿 | | | 总股本：3.85亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 157,357,180.82 | 67,182,856.85 | 388,319,392.98 | 298,606,173.49 |
| 营业总成本 | 129,665,410.33 | 55,423,758.66 | 310,478,518.94 | 225,319,472.13 |
| 其他经营收益 | | | | |
| 营业利润 | 16,584,474.83 | 7,290,434.57 | 44,244,477.86 | 38,887,214.29 |
| 利润总额 | 16,717,956.19 | 7,263,417.82 | 44,161,885.27 | 38,720,027.55 |
| 净利润 | 14,760,272.46 | 6,642,724.56 | 40,687,937.25 | 32,674,231.07 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 40,319.46 | - |
| 综合收益总额 | 14,760,272.46 | 6,642,724.56 | 40,728,256.71 | 32,674,231.07 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 523,698,484.4 | 556,291,882.1 | 565,414,570.53 | 578,584,857.41 |
| 非流动资产: | | | | |
| 非流动资产合计 | 541,435,606.46 | 536,914,885.05 | 532,155,763.19 | 542,060,543.91 |
| 资产总计 | 1,065,134,090.86 | 1,093,206,767.15 | 1,097,570,333.72 | 1,120,645,401.32 |
| 流动负债: | | | | |
| 流动负债合计 | 215,069,368.13 | 235,460,885.49 | 246,843,599.68 | 277,909,109.61 |
| 非流动负债: | | | | |
| 非流动负债合计 | 49,403,385.4 | 49,265,128.58 | 48,888,705.52 | 48,915,642.35 |
| 负债合计 | 264,472,753.53 | 284,726,014.07 | 295,732,305.2 | 326,824,751.96 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 800,661,337.33 | 808,480,753.08 | 801,838,028.52 | 793,820,649.36 |
| 股东权益合计 | 800,661,337.33 | 808,480,753.08 | 801,838,028.52 | 793,820,649.36 |
| 负债和股东权益合计 | 1,065,134,090.86 | 1,093,206,767.15 | 1,097,570,333.72 | 1,120,645,401.32 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 131,484,975.41 | 61,008,490.84 | 342,224,636.44 | 245,739,490.16 |
| 经营活动现金流出小计 | 132,497,014.7 | 70,645,085.33 | 311,806,072.01 | 233,374,652.26 |
| 经营活动产生的现金流量净额 | -1,012,039.29 | -9,636,594.49 | 30,418,564.43 | 12,364,837.9 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 692,208,708.7 | 243,259,643.79 | 887,240,547.73 | 470,627,449.59 |
| 投资活动现金流出小计 | 905,836,697.69 | 483,817,093.06 | 906,445,051.66 | 669,350,850.52 |
| 投资活动产生的现金流量净额 | -213,627,988.99 | -240,557,449.27 | -19,204,503.93 | -198,723,400.93 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 20,000,000 | 20,000,000 | 2,564,700 | 2,564,700 |
| 筹资活动现金流出小计 | 35,461,693.18 | 79,787.78 | - | - |
| 筹资活动产生的现金流量净额 | -15,461,693.18 | 19,920,212.22 | 2,564,700 | 2,564,700 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -230,101,721.46 | -230,273,831.54 | 13,778,760.5 | -183,793,863.03 |
| 期末现金及现金等价物余额 | 55,725,167.29 | 55,553,057.21 | 285,826,888.75 | 88,254,265.22 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -230,101,721.46 | - | 13,778,760.5 | - |